Irl Greenwell to Humans
This is a "connection" page, showing publications Irl Greenwell has written about Humans.
Connection Strength
0.145
-
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Leuk Lymphoma. 2022 11; 63(11):2757-2759.
Score: 0.031
-
When to use stem cell transplant in mantle cell lymphoma. Expert Rev Hematol. 2019 04; 12(4):207-210.
Score: 0.025
-
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Cancer. 2018 06 01; 124(11):2306-2315.
Score: 0.023
-
PI3K Inhibitors: Understanding Toxicity Mechanisms and Management. Oncology (Williston Park). 2017 11 15; 31(11):821-8.
Score: 0.023
-
Disaster 101: a novel approach to disaster medicine training for health professionals. J Emerg Med. 2010 Aug; 39(2):220-6.
Score: 0.013
-
Postibrutinib relapse outcomes for patients with marginal zone lymphoma. Blood Adv. 2023 01 10; 7(1):88-91.
Score: 0.008
-
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study. J Hematol Oncol. 2022 07 16; 15(1):96.
Score: 0.008
-
Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation. Cancer Genet. 2022 01; 260-261:18-22.
Score: 0.007
-
Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow. Expert Rev Anticancer Ther. 2017 Mar; 17(3):271-279.
Score: 0.005